Canadian dermatologists assess benefits of new treatments A new biologic for psoriasis and a new tyrosine kinase-2 inhibitor for psoriasis, the long-term safety ofan IL-17 to treat pediatric patients with psoriasis, the availability of a new laser to treat acne, more options for atopic dermatitis (AD) patients, and expanding the use of deroofing in the […]
